HHS hammers industry's attempt to delay new drug price negotiations
Lawyers for HHS on Friday sharply criticized the US Chamber of Commerce’s attempt to stall the implementation of new drug pricing negotiations, set to begin …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.